Vanguard Group Inc Sight Sciences, Inc. Transaction History

Vanguard Group Inc

$5.12 Trillion
Q2 2024

A detailed history of Vanguard Group Inc transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,646,547 shares of SGHT stock, worth $8.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,646,547

Previous 1,556,450 5.79%

Holding current value

$8.71 Million

Previous $8.22 Million 33.63%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.13 - $7.15 $462,197 - $644,193	90,097 Added 5.79%	1,646,547 $11 Million
Q1 2024 May 10, 2024	BUY	$4.02 - $5.89 $328,707 - $481,613	81,768 Added 5.54%	1,556,450 $8.22 Million
Q4 2023 Feb 14, 2024	BUY	$1.29 - $5.86 $83,490 - $379,265	64,721 Added 4.59%	1,474,682 $7.61 Million
Q3 2023 Nov 14, 2023	BUY	$2.88 - $8.8 $9,927 - $30,333	3,447 Added 0.25%	1,409,961 $4.75 Million
Q2 2023 Aug 14, 2023	BUY	$7.46 - $10.67 $114,428 - $163,667	15,339 Added 1.1%	1,406,514 $11.6 Million
Q1 2023 May 15, 2023	BUY	$8.44 - $13.35 $189,967 - $300,481	22,508 Added 1.64%	1,391,175 $12.2 Million
Q4 2022 Feb 10, 2023	BUY	$5.58 - $13.94 $19,290 - $48,190	3,457 Added 0.25%	1,368,667 $16.7 Million
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $1.43 Million - $2.68 Million	234,716 Added 20.76%	1,365,210 $8.67 Million
Q2 2022 Aug 12, 2022	BUY	$6.61 - $11.99 $315,753 - $572,750	47,769 Added 4.41%	1,130,494 $10.2 Million
Q1 2022 May 13, 2022	BUY	$11.56 - $17.9 $6.03 Million - $9.33 Million	521,412 Added 92.89%	1,082,725 $12.5 Million
Q4 2021 Feb 14, 2022	SELL	$17.36 - $27.36 $13.4 Million - $21.1 Million	-770,617 Reduced 57.86%	561,313 $9.86 Million
Q3 2021 Nov 12, 2021	BUY	$22.34 - $39.1 $29.8 Million - $52.1 Million	1,331,930 New	1,331,930 $30.2 Million

Others Institutions Holding SGHT

# of Institutions

Shares Held

21.4M

Call Options Held

30.7K

Put Options Held

18.6K

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $253M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Sight Sciences, Inc. Transaction History